Statute Details
- Title: Securities and Futures (Prescribed Entities) Order 2005
- Act Code: SFA2001-S608-2005
- Legislation Type: Subsidiary Legislation (SL)
- Authorising Act: Securities and Futures Act (Cap. 289)
- Enacting Authority: Monetary Authority of Singapore (MAS)
- Commencement: 15 October 2005
- Current Status (as provided): Current version as at 27 March 2026
- Key Provisions: Section 1 (Citation and commencement); Section 2 (Prescribed entities); Section 3 (Cancellation); Schedule (list of prescribed entities)
- Relevant SFA Provisions (as referenced): Sections 239(4) and 261(1B) of the Securities and Futures Act
- Instrument Number: SL 608/2005
- Made Date: 19 September 2005
What Is This Legislation About?
The Securities and Futures (Prescribed Entities) Order 2005 is a Singapore subsidiary legislation instrument made by the Monetary Authority of Singapore (MAS) under the Securities and Futures Act (SFA). In practical terms, it is a “designation” order: it identifies specific organisations as prescribed entities for the purposes of certain provisions in the SFA.
Although the extract provided is brief, the legal function of the Order is clear. Section 2 empowers MAS to declare entities listed in the Schedule as “prescribed entities”. Those designations matter because the SFA provisions referenced—sections 239(4) and 261(1B)—attach regulatory consequences to whether an entity is “prescribed”. In other words, the Order does not itself create a comprehensive regulatory regime; rather, it operates as a targeted mechanism that determines which entities fall within particular statutory pathways.
The Order also includes a transitional/cleanup component. Section 3 cancels an earlier instrument, the Securities and Futures (Prescribed Corporations) Notification (N 1). This suggests that the regulatory framework was updated, with the “prescribed” concept being reorganised or re-expressed through an Order format and/or updated statutory references.
What Are the Key Provisions?
Section 1: Citation and commencement. Section 1 provides the formal citation of the instrument and states that it comes into operation on 15 October 2005. For practitioners, commencement is important because it determines from what date the designation of prescribed entities becomes legally effective for the relevant SFA provisions.
Section 2: Prescribed entities. This is the core provision. Section 2 states that MAS “hereby declares the entities set out in the Schedule to be prescribed entities for the purposes of sections 239(4) and 261(1B) of the Act.” The legal effect is that the Schedule is determinative: the entities listed there are the ones that qualify as “prescribed entities” under the specified SFA provisions.
From a lawyer’s perspective, the key work is not merely reading Section 2, but mapping the designation to the consequences in the SFA. The Order’s wording is deliberately narrow: it ties the designation to two specific SFA sections. That means the “prescribed entity” status is not necessarily a general label for all SFA contexts; instead, it is a status that is relevant to particular statutory triggers. Practitioners should therefore treat the Order as a cross-reference tool: confirm the entity is in the Schedule, then determine how sections 239(4) and 261(1B) operate.
Section 3: Cancellation. Section 3 cancels the Securities and Futures (Prescribed Corporations) Notification (N 1). Cancellation provisions are legally significant because they prevent overlap and potential uncertainty about which instrument governs. Where an earlier notification is cancelled, reliance on that earlier designation may no longer be correct after the cancellation takes effect (subject to any transitional provisions in the SFA or in amending instruments—none are shown in the extract). In practice, counsel should check whether any transitional arrangements exist in the SFA amendments or subsequent orders.
The Schedule: the list of prescribed entities. While the extract does not reproduce the Schedule contents, it is central to the Order. The Schedule is where the actual entities are enumerated. For compliance and advice, the Schedule is the “fact” that must be verified. If an entity is not listed, it will not be a prescribed entity for the purposes of the referenced SFA provisions, even if it is similar to an entity that is listed.
How Is This Legislation Structured?
The Order is structured in a straightforward, instrument-style format typical of MAS subsidiary legislation:
(1) Enacting formula and operative provisions. The enacting formula states that MAS makes the Order under powers conferred by sections 239(4) and 261(1B) of the SFA (as amended by the Securities and Futures (Amendment) Act 2005). This indicates that the Order is part of a broader legislative amendment package.
(2) Section 1 (Citation and commencement). This provides the legal identity and start date.
(3) Section 2 (Prescribed entities). This is the designation mechanism, pointing to the Schedule.
(4) Section 3 (Cancellation). This removes an earlier instrument from the legal landscape.
(5) The Schedule. The Schedule lists the entities that are prescribed. In practice, the Schedule is the most operational part for regulated entities and their advisers.
Who Does This Legislation Apply To?
The Order applies to entities that are named in the Schedule. However, the practical “audience” is broader: it includes any person or organisation whose regulatory obligations under the SFA depend on whether another entity is a “prescribed entity”.
Accordingly, the Order is relevant to:
- Financial institutions and market participants that must assess counterparties or counterpart categories under the SFA framework;
- Legal advisers and compliance teams who must determine whether a particular entity falls within statutory definitions or exemptions that hinge on “prescribed entity” status;
- Entities potentially affected by regulatory consequences tied to sections 239(4) and 261(1B), once their status is confirmed against the Schedule.
Because the extract does not show the Schedule, it is not possible to identify the specific entities designated. In practice, counsel should obtain the current version of the Schedule (noting the “current version as at 27 March 2026” status) and verify whether the relevant entity is listed. If the entity is listed, it will be treated as a prescribed entity for the specified SFA purposes; if not, the entity will fall outside that designation.
Why Is This Legislation Important?
Although the Order is short, it can have significant downstream effects. In financial regulation, many obligations are triggered by definitions and categories—such as whether a counterparty is a particular type of regulated or designated entity. By prescribing entities, MAS effectively determines which organisations are captured by certain statutory provisions in the SFA.
For practitioners, the importance lies in certainty and compliance. When advising on regulatory obligations, counsel must be able to answer questions like: “Does the statutory provision apply because the entity is prescribed?” If the answer depends on a Schedule list, the Order becomes a critical reference document. Missing or misunderstanding the designation can lead to incorrect compliance assessments, misclassification of counterparties, or flawed legal opinions.
The cancellation in Section 3 also matters. Regulatory regimes evolve, and earlier instruments may be replaced. If a firm continues to rely on the cancelled Notification (N 1), it risks using outdated designations. The Order therefore serves both as an updated legal basis for prescribed entities and as a signal that the regulatory framework has been reorganised.
Finally, because the Order is made under specific SFA sections, it is best understood as a targeted instrument rather than a standalone regulatory rulebook. The practitioner’s task is to read the Order alongside sections 239(4) and 261(1B) of the SFA to determine the exact legal consequences of being “prescribed”. That cross-reading is where the real legal work occurs.
Related Legislation
- Securities and Futures Act (Cap. 289) — particularly sections 239(4) and 261(1B)
- Securities and Futures (Prescribed Corporations) Notification (N 1) — cancelled by Section 3 of this Order
- Securities and Futures (Amendment) Act 2005 (Act 1 of 2005) — referenced in the enacting formula as part of the amendment context
Source Documents
This article provides an overview of the Securities and Futures (Prescribed Entities) Order 2005 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.